131 related articles for article (PubMed ID: 15731541)
1. Efficacy of acute inhalation of nitric oxide in patients with primary pulmonary hypertension using chronic use of continuous epoprostenol infusion.
Saji K; Sakuma M; Suzuki J; Takahashi T; Demachi J; Nawata J; Kitamukai O; Onoue N; Sugimura K; Tada T; Fukui S; Kagaya Y; Watanabe J; Shirato K
Circ J; 2005 Mar; 69(3):335-8. PubMed ID: 15731541
[TBL] [Abstract][Full Text] [Related]
2. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of sildenafil in patients with primary pulmonary hypertension receiving epoprostenol.
Kuhn KP; Wickersham NE; Robbins IM; Byrne DW
Exp Lung Res; 2004 Mar; 30(2):135-45. PubMed ID: 14972773
[TBL] [Abstract][Full Text] [Related]
4. Inhaled nitric oxide for the adult respiratory distress syndrome.
Rossaint R; Falke KJ; López F; Slama K; Pison U; Zapol WM
N Engl J Med; 1993 Feb; 328(6):399-405. PubMed ID: 8357359
[TBL] [Abstract][Full Text] [Related]
5. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
Haraldsson A; Kieler-Jensen N; Nathorst-Westfelt U; Bergh CH; Ricksten SE
Chest; 1998 Sep; 114(3):780-6. PubMed ID: 9743166
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.
Hoeper MM; Olschewski H; Ghofrani HA; Wilkens H; Winkler J; Borst MM; Niedermeyer J; Fabel H; Seeger W
J Am Coll Cardiol; 2000 Jan; 35(1):176-82. PubMed ID: 10636277
[TBL] [Abstract][Full Text] [Related]
7. Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.
Petkov V; Ziesche R; Mosgoeller W; Schenk P; Vonbank K; Stiebellehner L; Raderer M; Brunner C; Kneussl M; Block LH
Thorax; 2001 Sep; 56(9):734-6. PubMed ID: 11514696
[TBL] [Abstract][Full Text] [Related]
8. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized study of inhaled prostacyclin versus nitric oxide in patients with residual pulmonary hypertension after pulmonary endarterectomy.
Abe S; Ishida K; Masuda M; Ueda H; Kohno H; Matsuura K; Tamura Y; Watanabe M; Matsumiya G
Gen Thorac Cardiovasc Surg; 2017 Mar; 65(3):153-159. PubMed ID: 27783213
[TBL] [Abstract][Full Text] [Related]
10. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
Kieler-Jensen N; Ricksten SE; Stenqvist O; Bergh CH; Lindelöv B; Wennmalm A; Waagstein F; Lundin S
J Heart Lung Transplant; 1994; 13(3):366-75. PubMed ID: 8061011
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide and prostacyclin lower suprasystemic pulmonary hypertension after cardiopulmonary bypass.
Schranz D; Huth R; Wippermann CF; Ritzerfeld S; Schmitt FX; Oelert H
Eur J Pediatr; 1993 Oct; 152(10):793-6. PubMed ID: 8223778
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
Voswinckel R; Reichenberger F; Enke B; Kreckel A; Krick S; Gall H; Schermuly RT; Grimminger F; Rubin LJ; Olschewski H; Seeger W; Ghofrani HA
Pulm Pharmacol Ther; 2008 Oct; 21(5):824-32. PubMed ID: 18657627
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
[TBL] [Abstract][Full Text] [Related]
15. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
16. Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension.
Hill LL; Pearl RG
J Appl Physiol (1985); 1999 Apr; 86(4):1160-4. PubMed ID: 10194197
[TBL] [Abstract][Full Text] [Related]
17. Inhaled nitric oxide versus prostacyclin in chronic shunt-induced pulmonary hypertension.
Wauthy P; Abdel Kafi S; Mooi WJ; Naeije R; Brimioulle S
J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1434-41. PubMed ID: 14666016
[TBL] [Abstract][Full Text] [Related]
18. Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology.
Krasuski RA; Warner JJ; Wang A; Harrison JK; Tapson VF; Bashore TM
J Am Coll Cardiol; 2000 Dec; 36(7):2204-11. PubMed ID: 11127462
[TBL] [Abstract][Full Text] [Related]
19. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension.
Cockrill BA; Kacmarek RM; Fifer MA; Bigatello LM; Ginns LC; Zapol WM; Semigran MJ
Chest; 2001 Jan; 119(1):128-36. PubMed ID: 11157594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
